Genetic Polymorphisms of Endothelial Nitric Oxide Synthase Associated with Hypertension and Blood Homocysteine Levels

References

• World Health Organization. Hypertension; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed December 4, 2022.
   Google Scholar
• Majić A, Arsenović D, Čvokić DD. Behavioral and metabolic risk factors for noncommunicable diseases among population in the Republic of Srpska (Bosnia and Herzegovina). Healthcare. 2023;11(4):483. doi:10.3390/healthcare11040483
   Web of Science ®Google Scholar
• Sakboonyarat B, Rangsin R, Kantiwong A, et al. Prevalence and associated factors of uncontrolled hypertension among high blood pressure patients: a nation-wide survey in Thailand. BMC Res Notes. 2019;12(1):380. doi:10.1186/s13104-019-4417-7
   PubMed Web of Science ®Google Scholar
• Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009;60(1):39–54. doi:10.1146/annurev.med.60.041807.123308
   PubMedGoogle Scholar
• Tinelli C, Di Pino A, Ficulle E, et al. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019;6:49. doi:10.3389/fnut.2019.00049
   PubMed Web of Science ®Google Scholar
• Tran SK, Ngo TH, Nguyen PH, et al. Hyperhomocysteinemia in patients with newly diagnosed primary hypertension in Can Tho City, Vietnam. Healthcare. 2023;11(2):234. doi:10.3390/healthcare11020234
   Web of Science ®Google Scholar
• Yang B, Fan S, Zhi X, et al. Interactions of homocysteine and conventional predisposing factors on hypertension in Chinese adults. J Clin Hypertens. 2017;19(11):1162–1170. doi:10.1111/jch.13075
   Web of Science ®Google Scholar
• Cyr AR, Huckaby LV, Shiva SS, et al. Nitric Oxide and Endothelial Dysfunction. Crit Care Clin. 2020;36(2):307–321. doi:10.1016/j.ccc.2019.12.009
   PubMed Web of Science ®Google Scholar
• Hermann M, Flammer A, Lüscher TF. Nitric oxide in hypertension. J Clin Hypertens. 2006;8(12 Suppl 4):17–29. doi:10.1111/j.1524-6175.2006.06032.x
   PubMedGoogle Scholar
• Shankarishan P, Borah PK, Ahmed G, et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population. Biomed Res Int. 2014;2014:793040. doi:10.1155/2014/793040
   PubMed Web of Science ®Google Scholar
• Midoun AA, Kiando SR, Treard C, et al. Genetic association study between T-786C NOS3 polymorphism and essential hypertension in an Algerian population of the Oran city. Diabetes Metab Syndr. 2019;13(2):1317–1320. doi:10.1016/j.dsx.2019.02.024
   PubMed Web of Science ®Google Scholar
• Niu WQ, Qi Y, Zhang LT, et al. Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J Hum Hypertens. 2009;23(2):136–139. doi:10.1038/jhh.2008.111
   PubMed Web of Science ®Google Scholar
• Xie X, Shi X, Xun X, et al. Endothelial nitric oxide synthase gene single nucleotide polymorphisms and the risk of hypertension: a meta-analysis involving 63,258 subjects. Clin Exp Hypertens. 2017;39(2):175–182. doi:10.1080/10641963.2016.1235177
   PubMed Web of Science ®Google Scholar
• Skeete J, DiPette DJ. Relationship between homocysteine and hypertension: new data add to the debate. J Clin Hypertens. 2017;19(11):1171–1172. doi:10.1111/jch.13073
   Web of Science ®Google Scholar
• Chen Z, Oliveira SDS, Zimnicka AM, et al. Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells. Mol Biol Cell. 2018;29(10):1190–1202. doi:10.1091/mbc.E17-01-0049
   PubMed Web of Science ®Google Scholar
• Stühlinger MC, Stanger O. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab. 2005;6(1):3–14. doi:10.2174/1389200052997393
   PubMed Web of Science ®Google Scholar
• Rodríguez Esparragón FJ, Rodríguez Pérez JC, Macías Reyes A, et al. Arterial blood pressure variations: homocysteine and nitric oxide synthase gene polymorphisms (NOS3). Nefrologia. 2006;26(5):559–563.
   PubMed Web of Science ®Google Scholar
• Vathesatogkit P, Woodward M, Tanomsup S, et al. Cohort profile: the electricity generating authority of Thailand study. Int J Epidemiol. 2012;41(2):359–365. doi:10.1093/ije/dyq218
   PubMed Web of Science ®Google Scholar
• Abbott, Abbott Architect System. Homocysteine; 2008. Available from: http://www.ilexmedical.com/files/PDF/Homocysteine_ARC.pdf. Accessed January 2, 2023.
   Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324. doi:10.1161/HYP.0000000000000066
   PubMed Web of Science ®Google Scholar
• The National Health Examination Survey Office, Health System Research Institute; 2014. Available from: https://www.hiso.or.th/hiso/picture/reportHealth/report/report9.pdf. Accessed January 15, 2022.
   Google Scholar
• Holven KB, Haugstad TS, Holm T, et al. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. Br J Nutr. 2003;89(3):359–363. doi:10.1079/BJN2002779
   PubMed Web of Science ®Google Scholar
• Momin M, Jia J, Fan F, et al. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids Health Dis. 2017;16(1):54. doi:10.1186/s12944-017-0441-6
   PubMedGoogle Scholar
• Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107(10):1263–1273. doi:10.1172/JCI11596
   PubMed Web of Science ®Google Scholar
• Vecoli C. Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease. In: Litwack G, editor. Vitamins & Hormones. 96: Academic Press; 2014:387–406.
   Google Scholar
• Zhao GL, Li QJ, Lu HY. Association between NOS3 genetic variants and coronary artery disease in the Han population. Genet Mol Res. 2016;15(2):1–4.
   Web of Science ®Google Scholar
• Heidari MM, Khatami M, Tahamtan Y. Molecular analysis of rs2070744 and rs1799983 polymorphisms of NOS3 gene in Iranian patients with multiple sclerosis. Basic Clin Neurosci. 2017;8(4):279–284. doi:10.18869/nirp.bcn.8.4.279
   PubMedGoogle Scholar
• Zmijewski P, Cieszczyk P, Ahmetov II, et al. The NOS3 G894T (rs1799983) and −786T/C (rs2070744) polymorphisms are associated with elite swimmer status. Biol Sport. 2018;35(4):313–319. doi:10.5114/biolsport.2018.76528
   PubMed Web of Science ®Google Scholar
• Hong Z, Pan L, Ma Z, et al. Combined effects of cigarette smoking, alcohol drinking and eNOS Glu298Asp polymorphism on blood pressure in Chinese male high blood pressure subjects. Tob Induc Dis. 2019;17:59. doi:10.18332/tid/110678
   PubMed Web of Science ®Google Scholar
• Zhao Q, Su SY, Chen SF, et al. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med J. 2006;119(13):1065–1071. doi:10.1097/00029330-200607010-00002
   PubMed Web of Science ®Google Scholar
• Niu W, Qi Y, Reitsma PH. An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One. 2011;6(9):e24266. doi:10.1371/journal.pone.0024266
   PubMed Web of Science ®Google Scholar
• Rossi GP, Taddei S, Virdis A, et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian high blood pressure patients. J Am Coll Cardiol. 2003;41(6):938–945. doi:10.1016/S0735-1097(02)03011-5
   PubMed Web of Science ®Google Scholar
• Cheng Z, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev. 2009;5(2):158–165. doi:10.2174/157340209788166940
   PubMedGoogle Scholar
• Fernandez ML, Ruiz R, Gonzalez MA, et al. Association of NOS3 gene with metabolic syndrome in high blood pressure patients. Thromb Haemost. 2004;92(2):413–418. doi:10.1160/TH04-02-0103
   PubMed Web of Science ®Google Scholar
• Gamil S, Erdmann J, Abdalrahman IB, et al. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet. 2017;18(1):128. doi:10.1186/s12881-017-0491-7
   PubMedGoogle Scholar
• Brown KS, Kluijtmans LA, Young IS, et al. Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia. Arterioscler Thromb Vasc Biol. 2003;23(6):1014–1020. doi:10.1161/01.ATV.0000071348.70527.F4
   PubMed Web of Science ®Google Scholar
• Roy R, Wilcox J, Webb AJ, O’Gallagher K. Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int J Mol Sci. 2023;24(20):15200. doi:10.3390/ijms242015200
   PubMed Web of Science ®Google Scholar